Cargando…

Race, Biomarkers, and Cardiovascular Disease in Patients With Chronic Kidney Disease

Detalles Bibliográficos
Autores principales:	Nicholas, Susanne B., Norris, Keith C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9683640/ https://www.ncbi.nlm.nih.gov/pubmed/36102224 http://dx.doi.org/10.1161/JAHA.122.026998

Ejemplares similares

Association of Race/Ethnicity, Inflammation, and Albuminuria in Patients With Diabetes and Early Chronic Kidney Disease
por: Sinha, Satyesh K., et al.
Publicado: (2014)

Race, ancestry, and genetic risk for kidney failure
por: Nicholas, Susanne B., et al.
Publicado: (2022)

Race, Interleukin‐6, TMPRSS6 Genotype, and Cardiovascular Disease in Patients With Chronic Kidney Disease
por: Barrows, Ian R., et al.
Publicado: (2022)

Statins and Cardiovascular Disease Outcomes in Chronic Kidney Disease: Reaffirmation vs. Repudiation
por: Obialo, Chamberlain I., et al.
Publicado: (2018)

Cathepsin S as an early biomarker for cardiovascular disease in chronic kidney disease patients
por: Sonkar, Satyendra Kumar, et al.
Publicado: (2022)

Osteopontin as a Biomarker in Chronic Kidney Disease
por: Sinha, Satyesh K., et al.
Publicado: (2023)

The Role of Vitamin D and Oxidative Stress in Chronic Kidney Disease
por: Norris, Keith C., et al.
Publicado: (2018)

Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease
por: Kim, Hyoungnae, et al.
Publicado: (2023)

Tryptophan levels associate with incident cardiovascular disease in chronic kidney disease
por: Konje, Vetalise C, et al.
Publicado: (2020)

Retaining Race in Chronic Kidney Disease Diagnosis and Treatment
por: Williams, Paul
Publicado: (2023)

Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019
por: Chu, Chi D., et al.
Publicado: (2021)

The association between race and income on risk of mortality in patients with moderate chronic kidney disease
por: Fedewa, Stacey A, et al.
Publicado: (2014)

The Role of Novel Biomarkers of Cardiovascular Disease in Chronic Kidney Disease: Focus on Adiponectin and Leptin
por: Kaisar, Omar M, et al.
Publicado: (2008)

Cardiovascular disease in patients with chronic kidney disease
por: Wright, Julian, et al.
Publicado: (2009)

Urea levels and cardiovascular disease in patients with chronic kidney disease
por: Laville, Solène M, et al.
Publicado: (2022)

Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease
por: Niizuma, Shinichiro, et al.
Publicado: (2017)

Biomarkers and Echocardiographic Predictors of Cardiovascular Outcome in Patients With Chronic Chagas Disease
por: Mendes, Veronica G., et al.
Publicado: (2023)

Patient Race/Ethnicity and Patient-Physician Race/Ethnicity Concordance in the Management of Cardiovascular Disease Risk Factors for Patients With Diabetes
por: Traylor, Ana H., et al.
Publicado: (2010)

Race and Alzheimer Disease Biomarkers: A Neglected Race
por: Lleó, Alberto, et al.
Publicado: (2021)

Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease
por: Forné, Carles, et al.
Publicado: (2019)

Cardiovascular Biomarkers in Chronic Kidney Disease: State of Current Research and Clinical Applicability
por: D'Marco, Luis, et al.
Publicado: (2015)

The Role of Prognostic and Predictive Biomarkers for Assessing Cardiovascular Risk in Chronic Kidney Disease Patients
por: Provenzano, Michele, et al.
Publicado: (2020)

Plasma Serotonin and Cardiovascular Outcomes in Chronic Kidney Disease
por: Edmonston, Daniel, et al.
Publicado: (2023)

Ankle Brachial Index and Subsequent Cardiovascular Disease Risk in Patients With Chronic Kidney Disease
por: Chen, Jing, et al.
Publicado: (2016)

Chronic Kidney Disease And Associated Risk Factors Among Cardiovascular Patients
por: Chala, Getahun, et al.
Publicado: (2019)

Impact of Chronic Kidney Disease on the Associations of Cardiovascular Biomarkers With Adverse Outcomes in Patients With Suspected or Known Coronary Artery Disease: The EXCEED‐J Study
por: Wada, Hiromichi, et al.
Publicado: (2022)

Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry
por: Tuttle, Katherine R., et al.
Publicado: (2019)

Biomarkers and Predictors of Adverse Cardiovascular Events in Different Stages of Chronic Kidney Disease
por: Stopic, Bojan, et al.
Publicado: (2022)

Depression and incident cardiovascular disease among patients with chronic kidney disease
por: D'Oro, Anthony, et al.
Publicado: (2023)

Cardiovascular Disease in Diabetes and Chronic Kidney Disease
por: Swamy, Sowmya, et al.
Publicado: (2023)

Nontraditional Cardiovascular Biomarkers and Estimation of Cardiovascular Risk in Predialysis Chronic Kidney Disease Patients and Their Correlations With Carotid Intima Media Thickness
por: Sathi, Satyanand, et al.
Publicado: (2014)

Religious Service Attendance and Mortality among Adults in the United States with Chronic Kidney Disease
por: Bruce, Marino A., et al.
Publicado: (2021)

Biomarker Profiling of Neurovascular Diseases in Patients with Stage 5 Chronic Kidney Disease
por: Lee, Justin, et al.
Publicado: (2018)

Excess Burden of Poverty and Hypertension, by Race and Ethnicity, on the Prevalence of Cardiovascular Disease
por: Sells, Michael L., et al.
Publicado: (2023)

Markers of increased cardiovascular risk in patients with chronic kidney disease
por: Gluba-Brzózka, Anna, et al.
Publicado: (2014)

10. Cardiovascular Risk in Chronic Kidney Disease
por: Lainščak, Mitja
Publicado: (2009)

Vitamin D Metabolites and Risk of Cardiovascular Disease in Chronic Kidney Disease: The CRIC Study
por: Hsu, Simon, et al.
Publicado: (2023)

Racial-ethnic diversity in ambulatory blood pressure monitoring in children with chronic kidney disease
por: Pagi, Reut, et al.
Publicado: (2022)

Risk for recurrent cardiovascular disease events among patients with diabetes and chronic kidney disease
por: Hubbard, Demetria, et al.
Publicado: (2021)

Impact of age on cardiovascular drug use in patients with chronic kidney disease
por: Villain, Cédric, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rocbh88i54l9frckr54bd033sb